 |
| Global Single Cell Genome Sequencing Market Size |
Single cell genome sequencing allows researchers to study complex biological
systems at a cellular level by sequencing genomes of individual cells. It helps
reveal heterogeneity and rare cell populations in tissues and tumors. This
provides invaluable insights into cell differentiation, gene expression
variability, and immune cell functions which is crucial for understanding
embryogenesis, cancer evolution and immunology.
The global
Single Cell Genome Sequencing Market is estimated to be valued at US$ 2.28 Bn in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The adoption of single cell genome sequencing in biopharmaceutical research and
drug discovery is one of the major trends boosting the market growth. Single
cell analysis helps in developing personalized medicines by enabling
researchers to identify biomarkers, drug resistance mechanisms and rare cell
populations. It is being extensively used to develop cell and gene therapies as
well as cancer immunotherapy. Single cell genome sequencing provides detailed
analysis of cell heterogeneity, mutations and interaction between different
cell types which is helpful for developing targeted therapies. The rising funds
for genomics research from government as well as private sources is also
fueling the demand for single cell sequencing solutions.
Segment Analysis
The global single cell genome sequencing market is dominated by clinical
applications segment. Clinical applications of single cell genome sequencing
help in understanding diseases at single cell level. It aids in developing
personalized treatment strategies by analysing genomic variations between
healthy and diseased cells. Further, rising incidence of chronic diseases is
driving growth of clinical applications segment.
Key Takeaways
Global
Single Cell Genome Sequencing Market Size Growth Accelerated By
Adoption Of Single Cell Genome Sequencing In Biopharma Research is expected to
witness high growth over the forecast period of 2023 to 2030. The global Single
Cell Genome Sequencing Market is estimated to be valued at US$ 2.28 Bn in 2023 and is
expected to exhibit a CAGR of 3.9% over
the forecast period 2023 to 2030.
Regional
analysis: North America dominated the market in 2023 with a share of over 35%,
due to presence of major players and extensive R&D activities in the
region. Asia Pacific is expected to be the fastest growing region on account of
rising government funding for genomics projects and increasing healthcare
expenditure.
Key players: Key players operating in the single cell genome sequencing market
are 10x Genomics, Fluidigm Corporation, Bio-Rad Laboratories, BGI, Illumina
Inc., Pacific Biosciences of California, Novogene Corporation, Danaher, Qiagen
and NanoString Technologies. 10x Genomics dominates the market owing to its
robust product portfolio for single cell genome sequencing and analysis.
Explore More Related Article On This
Topic: https://www.newsanalyticspro.com/the-single-cell-genome-sequencing-market-is-poised-for-remarkable-growth/
Explore More Related Article: https://themediumblog.com/training-market-is-estimated-to-witness-high-growth/